• Info
  • Insider Ownership

Insider Trading & Ownership of Laurie B. Keating

Location
Cambridge, MA
Summary
The estimated net worth of Laurie B. Keating is at least $1,031,491 dollars as of 02 Jan 2026. Laurie B. Keating is the EVP, Chief Legal Officer of ALNYLAM PHARMACEUTICALS, INC. and owns shares of ALNYLAM PHARMACEUTICALS, INC. (ALNY) stock worth about $1.03M.
Signature
/s/ Michael D. Bookman, Attorney-in-Fact for Laurie B. Keating
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow Laurie B. Keating and return when a new Insider Trading filing appears.

This tracks SEC filing changes for this page using existing product update flows.

Sign up to follow filing activity

Sponsored

Quick Takeaways

  • Laurie B. Keating has 4 issuer positions tracked on this page.
  • Estimated disclosed ownership value: $1,031,491.
  • Recent insider filing activity is available below.

What Changed

  • Largest disclosed position: ALNYLAM PHARMACEUTICALS, INC. ($1,031,491).
  • Past-year value change for that position: .

Why This Matters

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Official SEC Source

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of Laurie B. Keating

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
ALNY ALNYLAM PHARMACEUTICALS, INC. EVP, Chief Legal Officer $1,031,491 05 Aug 2021
IMGO Imago BioSciences, Inc. Director 11 Jan 2023
IMRX Immuneering Corp Director 01 Jan 2026
PEPG PepGen Inc. Director 04 Jun 2025

Insider Transactions Reported by Laurie B. Keating:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Sponsored